Federica Delbello | Rehabilitation Science | Research Excellence Award

Published on by Health Scientists

Mrs. Federica Delbello | Rehabilitation Science | Research Excellence Award

Azienda Sanitaria Unversitaria Friuli Centrale | Italy

Dr. Federica Delbello is a distinguished researcher at the Spinal Unit in Udine, Italy, specializing in spinal surgery, arthrodesis, and the radiological assessment of spinal stabilization techniques. Her research primarily focuses on evaluating the accuracy and reliability of radiological methods for assessing spinal fusion, providing evidence-based insights to enhance surgical precision and patient outcomes. To date, she has authored 4 publications, with 4 citations and an h-index of 1, reflecting her growing influence in the field. Dr. Delbello actively collaborates with an international network of 9 co-authors, promoting interdisciplinary research and knowledge exchange. Her work not only advances clinical understanding of spinal fusion assessment but also supports the development of improved diagnostic protocols and rehabilitation strategies. Through rigorous systematic reviews and applied clinical research, Dr. Delbello contributes to global efforts in optimizing spinal health, improving patient safety, and fostering innovation in spinal surgery and rehabilitation practices.

Citation Metrics (Scopus)

4
3
2
1
0

Citations

4

Documents

4

h-index

1

Citations

Documents

h-index

View Scopus Profile View ORCID Profile

Featured Publications


Accuracy and reliability of radiological methods for assessing fusion rates in patients undergoing spinal arthrodesis and stabilization: A systematic review of the past 10 years

– Bilancia, G., Contartese, D., Delbello, F., Tedesco, G., Salamanna, F., Griffoni, C., Gasbarrini, A., Giavaresi, G., & Spinnato, P., Frontiers in Surgery, 2025

Gao Yanjing | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Prof. Gao Yanjing | Clinical Medicine | Research Excellence Award

Chief Physician | Qilu Hospital of Shandong University | China

Gao Yanjing is a clinician–scientist and chief physician in gastroenterology at Qilu Hospital of Shandong University, with extensive expertise in liver cirrhosis, portal hypertension, gastrointestinal bleeding, and thrombotic complications of chronic liver disease. Trained in internal and clinical medicine, Gao has built a sustained academic career integrating patient-centered clinical practice with translational research. The work has resulted in a substantial body of peer-reviewed publications in leading international journals, with broad scholarly visibility and frequent citation within hepatology and gastroenterology research communities. Gao has led and participated in multicenter randomized clinical studies and investigator-initiated projects, and has collaborated closely with national and international institutions, including overseas academic medical centers. The research has directly informed clinical decision-making, optimized therapeutic strategies for cirrhosis-related complications, and contributed to improved patient outcomes and evidence-based gastrointestinal care. The researcher has 587 citations from 50 documents, with an h-index of 15.

Citation Metrics (Scopus)

600
400
200
0

Citations
587

Documents
50

h-index
15

🟦 Citations        🟥 Documents      🟩 h-index

View Google Scholar Profile
 View Scopus Profile

Featured Publications

Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Published on by Health Scientists

Mr. Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Assistant Professor | I.M. Sechenov First Moscow State Medical University | Russia

Dr. Zelimkhan Berikkhanov is a clinician-scientist whose work spans thoracic surgery, pulmonology, infectious diseases, oncology, and public health, with a strong emphasis on developing evidence-based approaches to complex respiratory and surgical disorders. His professional career integrates academic leadership as an assistant professor and methodologist with active clinical responsibilities at the National Medical Research Center for Pulmonology and Sechenov University, where he contributes to advanced surgical care, methodological development, and multidisciplinary education. His research portfolio reflects a diverse and impactful scholarly trajectory, encompassing peer-reviewed studies on tracheal reconstruction, thoracic oncology, diaphragmatic trauma, critical respiratory conditions, chronic obstructive pulmonary disease, COVID-associated pneumonia, nanomaterials in gastrointestinal pathology, digital tools in chronic disease management, and telemedicine in pulmonology. He has collaborated extensively with leading national and international experts, contributing to multi-center investigations, clinical guidelines, and translational research aimed at improving diagnostic accuracy, postoperative outcomes, and respiratory care pathways. His scientific productivity is demonstrated through a broad range of publications across high-quality journals, addressing both fundamental mechanisms and applied clinical innovations. His work on COVID-19 significantly advanced understanding of silent hypoxemia, cavitary lung disease, vibroacoustic therapy, and pharmacologic strategies, while his contributions to thoracic surgery strengthened evidence on complex tracheal and bronchial interventions. His participation in research on artificial intelligence for mortality prediction, biomarkers for pulmonary hypertension, metabolic instability in malignancies, and advanced imaging of the lymphatic system underscores his commitment to cross-disciplinary innovation. Through active collaboration, methodological leadership, and involvement in forward-looking clinical studies, Dr. Berikkhanov has helped shape modern approaches to respiratory medicine and thoracic surgery, generating insights that support better patient outcomes and inform national strategies in pulmonary care. His work continues to influence clinical practice, strengthen scientific networks, and enhance healthcare delivery through integrated, technology-supported, and patient-centered frameworks. He has 62 citations from 27 documents with an h-index of 4.

Profiles:  Scopus | ORCID

Featured Publications

1. Sukhanova, M. A., Muraviev, S. Y., Tarabrin, E. A., Shestakov, A. L., Berikkhanov, Z. G. M., Tarasova, I. A., Razumovsky, V. S., Markov, I. A., & Fabrika, A. P. (2025). The role of “metabolic instability” as a new risk criterion in the pathogenesis of endometrial cancer. Cancers.

2. Nagatkina, O. V., Proshkina, A. A., Makarova, N. M., Sokolova, E. S., Merzhoeva, Z. M., Nikitina, L. Y., Nuralieva, G. S., Berikchanov, Z. G., Ainetdinov, R. M., & Avdeev, S. N. (2025). Digital technologies for outpatient management of patients with chronic obstructive pulmonary disease: Opportunities to reduce the burden of the disease. Russian Journal of Preventive Medicine.

3. Ma, T., Berikkhanov, Z. G., Timashev, P. S., Khristidis, Y. I., Ivanova, M. Y., Ershov, B. P., Liu, T., & Tarabrin, E. A. (2025). A comparative study to evaluate the efficacy of sealants alone and in combination with collagen sheet in a pig isolated lung air leak model. Russian Journal of Operative Surgery and Clinical Anatomy.

4. Razumovsky, V. S., Tarabrin, E. A., Muravyov, S. Y., Berikkhanov, Z. G. M., & Konosevich, D. O. (2025). Diagnostics and visualization of the lymphatic system in clinical practice. Russian Sklifosovsky Journal “Emergency Medical Care.

5. Avdeev, S. N., Gaynitdinova, V. V., Merzhoeva, Z. M., Nuralieva, G. S., Tarabrin, E. A., Berikkhanov, Z. G., Nikitina, L. Y., Gneusheva, T. Y., Sokolova, E. S., Ainetdinov, R. M., et al. (2025). NT-proCNP as a new biomarker of pulmonary hypertension in patients with COPD. Scientific Reports.

Matiyas Mamo Bekele | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Mr. Matiyas Mamo Bekele | Clinical Medicine | Research Excellence Award

lecturer | University of Gondar | Ethiopia

Matiyas Mamo Bekele is an emerging optometry professional and clinical researcher whose work spans community eye health, refractive error–related quality of life, low-vision challenges, spectacle use, and the broader landscape of preventable visual impairment. As an academic and clinician at the University of Gondar, he integrates teaching, research, and service, contributing to the development of future optometrists, ophthalmic nurses, and ophthalmology residents while also providing comprehensive eye care through both static and outreach platforms. His scholarly work demonstrates a strong orientation toward population-based ophthalmic research, with multiple peer-reviewed publications addressing eye care utilization patterns, spectacle coverage, knowledge and attitudes toward vision correction, and the burden of ocular diseases among diverse communities and at-risk groups, including individuals with diabetes. His collaborative projects with multidisciplinary teams across hospitals, academic institutions, and public health units reflect a commitment to generating evidence that informs national strategies for equitable eye health access. Through his engagement in systematic reviews, clinical investigations, and community-focused studies, he contributes to a growing body of knowledge that supports early detection, appropriate referral pathways, and improved service delivery in low-resource settings. His involvement in national professional bodies and international volunteer organizations further underscores his dedication to strengthening training systems, capacity building, and vision-related advocacy. As a research advisor and mentor, he supports emerging scholars in pursuing impactful inquiry that addresses gaps in vision care and public health. His continuing work advances the understanding of refractive error needs, ocular morbidities, and community-based approaches to blindness prevention, positioned toward improving quality of life and reducing avoidable vision loss across broader populations. He has 10 citations from 13 documents with an h-index of 2.

Profiles: Scopus | ORCID

Featured Publications

1. Hulleck, A. A., Mohan, D. M., Abdallah, N., El Rich, M., & Khalaf, K. (2022). Present and future of gait assessment in clinical practice: Towards the application of novel trends and technologies.

2. Mohan, D. M., Khandoker, A. H., Wasti, S. A., Ismail Alali, S. I. I., & colleagues. (2021). Assessment methods of post-stroke gait: A scoping review of technology-driven approaches to gait characterization and analysis.

3. Jelinek, H. F., Osman, W. M., Khandoker, A. H., Khalaf, K., Lee, S., Almahmeed, W., & colleagues. (2017). Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates.

4. Maschirow, L., Khalaf, K., Al-Aubaidy, H. A., & Jelinek, H. F. (2015). Inflammation, coagulation, endothelial dysfunction and oxidative stress in prediabetes—Biomarkers as a possible tool for early disease detection for rural screening.

5. Witzel, I. I., Jelinek, H. F., Khalaf, K., Lee, S., Khandoker, A. H., & Alsafar, H. (2015). Identifying common genetic risk factors of diabetic neuropathies.

Tana Takacova | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Tana Takacova | Clinical Medicine | Best Researcher Award

Oncologist | Asklepios Klinik Altona | Germany

Tana Takacova is a physician-scientist specializing in hematology, oncology, and internal medicine with a distinguished academic and clinical trajectory across leading European research and tertiary care institutions. Her expertise spans immuno-oncology, molecular oncology, hematologic malignancies, and translational cancer research, supported by advanced training in oncology from a major German university and extensive postgraduate exposure to molecular biosciences in the United States. She has held clinical roles in prominent university-affiliated hospitals, progressing through multidisciplinary departments including hematology, oncology, palliative medicine, internal medicine, rheumatology, nephrology, gastroenterology, and cardiology, complemented by ongoing training as a prehospital emergency physician. Dr. Takacova has contributed to multiple international research collaborations across Germany, Denmark, Italy, and Slovakia, advancing knowledge in cancer genetics, circulating tumor DNA, oncolytic virus-checkpoint inhibitor synergies, renal cell carcinoma biomarkers, and therapy response prediction. Her peer-reviewed scholarship includes original research articles, systematic reviews, and case-based contributions in oncology and immunology, with additional manuscripts in review and development, reflecting a sustained commitment to evidence-based innovation and emerging therapeutic paradigms in precision oncology. She has presented at international oncology and pharmacology congresses and participates in global research networks and professional societies, reinforcing a truly international academic presence. Her work integrates advanced laboratory skills, clinical trial supervision, systematic review methodology, and bioinformatics-supported analysis, underscoring strong translational orientation. She has been recognized by competitive research fellowships and academic awards and contributes to open-access medical knowledge through educational initiatives such as a freely accessible hematology atlas. Fluent in multiple languages and trained across diverse health systems, she brings a global perspective, resilience in high-pressure environments, and a collaborative approach to clinical care and research leadership, driven by a commitment to advancing cancer diagnostics, therapeutic precision, and equitable patient outcomes worldwide. She has 34 citations from 4 documents with an h-index of 2.

Profile: Scopus

Featured Publications

1. Tana Takacova (2025). Paraneoplastic papillitis as a precursor to colon carcinoma: A case of unexpected vision loss leading to early cancer detection. Oncology Research and Treatment.

Jian Feng | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Jian Feng | Clinical Medicine | Best Researcher Award

Doctor | The General Hospital of Western Theater Command | China

Dr. Jian Feng is an Attending Physician at the Intensive Care Unit of The General Hospital of Western Theater Command in Chengdu, Sichuan Province, China. He earned his medical degree and completed advanced training in critical care medicine, with a focus on sepsis, multiple organ failure, acute respiratory distress syndrome, and altitude sickness. Dr. Feng has led and participated in multiple provincial- and national-level research projects, including studies on ICU-acquired weakness, the role of curcumin in skeletal muscle preservation at high altitudes, and innovative interventions in critical care. He has published extensively, with over 11 SCI-indexed papers and numerous Chinese core journal articles as first or corresponding author, including high-impact works in Asian Journal of Surgery, Journal of Inflammation Research, and Frontiers in Cellular and Infection Microbiology. His contributions extend to medical innovation, holding multiple invention and utility model patents, and co-authoring the monograph Clinical Nutritional Therapy for Neurocritical Care. Dr. Feng has received recognition for his research and clinical excellence, including awards for innovation and translational medicine. Beyond his research, he serves as a reviewer for prestigious journals such as Heliyon and Medical Science Monitor, demonstrating his commitment to advancing scientific rigor and critical peer review in the field of critical care medicine. His work combines clinical expertise with innovative research, reflecting a dedication to improving patient outcomes and contributing to the scientific community at both national and international levels. He has 51 citations from 20 documents with an h-index of 4.

Profiles: Scopus | ORCID

Featured Publications

1. Wang, M., Huang, B., Chen, J., Rui, Z., Li, J., Fang, S., Fan, L., Feng, J., & Li, F. (2025). Artificial intelligence and machine learning in the research and application status of ICU-acquired weakness.

2. Liu, J., Xu, Z., Luo, S., Bai, Y., Feng, J., & Li, F. (2024). Risk factors for ICU-acquired weakness in sepsis patients: A retrospective study of 264 patients.

3. Tan, J., Huang, B., Luo, S., Li, R., Hou, J., Zhang, R., Wang, L., Liu, Y., Li, F., & Feng, J. (2024). A rare case of severe pneumonia combined with septic shock caused by Nocardia amamiensis.

4. Luo, H., Feng, J., Xue, G., Zhang, Y., Li, Y., Huang, X., Chen, X., You, S., Dong, H., & Li, L. (2023). Comparative efficacy and acceptability of 12 phosphorus-lowering drugs in adults with hyperphosphatemia and chronic kidney disease: A systematic review and network meta-analysis.

5. Luo, S., Wang, L., Xu, Z., Liu, J., Zhang, W., Feng, J., & Li, F. (2023). Isolation, identification and biological characteristics of phage vB-KpnP1 for carbapenem-resistant Klebsiella pneumoniae.